Search Results

There are 1853 results for: content related to: Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma

  1. You have free access to this content
    Identification of FDA-approved Drugs that Computationally Bind to MDM2

    Chemical Biology & Drug Design

    Volume 80, Issue 4, October 2012, Pages: 631–637, Wayne A. Warner, Ricardo Sanchez, Alex Dawoodian, Esther Li and Jamil Momand

    Article first published online : 23 JUL 2012, DOI: 10.1111/j.1747-0285.2012.01428.x

  2. You have open access to this content
    Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells

    Cancer Science

    Volume 102, Issue 3, March 2011, Pages: 605–613, Shinji Endo, Kenji Yamato, Sachiko Hirai, Toshikazu Moriwaki, Kuniaki Fukuda, Hideo Suzuki, Masato Abei, Ichiro Nakagawa and Ichinosuke Hyodo

    Article first published online : 12 JAN 2011, DOI: 10.1111/j.1349-7006.2010.01821.x

  3. You have full text access to this OnlineOpen article
    Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A

    International Journal of Cancer

    Volume 121, Issue 1, 1 July 2007, Pages: 199–205, Christoph R. Müller, Erik B. Paulsen, Paul Noordhuis, Florence Pedeutour, Gunnar Sæter and Ola Myklebost

    Article first published online : 12 MAR 2007, DOI: 10.1002/ijc.22643

  4. MDM2 gene amplification in colorectal cancer is associated with disease progression at the primary site, but inversely correlated with distant metastasis

    Genes, Chromosomes and Cancer

    Volume 49, Issue 7, July 2010, Pages: 620–629, Nobuhiro Sugano, Tetsuji Suda, Ten-I Godai, Kazuhito Tsuchida, Manabu Shiozawa, Hironobu Sekiguchi, Mitsuyo Yoshihara, Shoichi Matsukuma, Yuji Sakuma, Eiju Tsuchiya, Yoichi Kameda, Makoto Akaike and Yohei Miyagi

    Article first published online : 13 APR 2010, DOI: 10.1002/gcc.20774

  5. Influence of MDM2 and MDM4 on development and survival in hereditary retinoblastoma

    Pediatric Blood & Cancer

    Volume 59, Issue 1, 15 July 2012, Pages: 39–43, Adriana Helena de Oliveira Reis, Ivna Néria Silva Ribamar de Carvalho, Paula Batista de Sousa Damasceno, Sima Esther Ferman, Evandro Lucena, Jorge Santiago Lopez-Camelo, Héctor N. Seuánez and Fernando Regla Vargas

    Article first published online : 16 DEC 2011, DOI: 10.1002/pbc.24014

  6. The Mdm Network and Its Regulation of p53 Activities: A Rheostat of Cancer Risk

    Human Mutation

    Christine M. Eischen and Guillermina Lozano

    Article first published online : 6 MAR 2014, DOI: 10.1002/humu.22524

  7. You have full text access to this OnlineOpen article
    Translational approaches targeting the p53 pathway for anti-cancer therapy

    British Journal of Pharmacology

    Volume 165, Issue 2, January 2012, Pages: 328–344, Frank Essmann and Klaus Schulze-Osthoff

    Article first published online : 16 DEC 2011, DOI: 10.1111/j.1476-5381.2011.01570.x

  8. MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma

    Pediatric Blood & Cancer

    Volume 53, Issue 4, October 2009, Pages: 576–583, Chiara Perfumo, Stefano Parodi, Katia Mazzocco, Raffaella Defferrari, Alberto Inga, Giovanna Bianchi Scarrà, Paola Ghiorzo, Riccardo Haupt, Gian Paolo Tonini and Gilberto Fronza

    Article first published online : 12 JUN 2009, DOI: 10.1002/pbc.22132

  9. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck

    Molecular Carcinogenesis

    Volume 50, Issue 9, September 2011, Pages: 697–706, Hongping Yu, Yu-jing Huang, Zhensheng Liu, Li-E Wang, Guojun Li, Erich M. Sturgis, David G. Johnson and Qingyi Wei

    Article first published online : 7 JUN 2011, DOI: 10.1002/mc.20806

  10. Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development

    The Journal of Pathology

    Volume 228, Issue 3, November 2012, Pages: 416–428, Qin Zhang, Xueyan He, Lai Chen, Chenxi Zhang, Xiang Gao, Zhongzhou Yang and Geng Liu

    Article first published online : 28 SEP 2012, DOI: 10.1002/path.4077

  11. Frequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes

    Histopathology

    Volume 60, Issue 2, January 2012, Pages: 357–359, Laure A E Duhamel, Hongtao Ye, Dina Halai, Bernadine D Idowu, Nadège Presneau, Roberto Tirabosco and Adrienne M Flanagan

    Article first published online : 10 NOV 2011, DOI: 10.1111/j.1365-2559.2011.04023.x

  12. You have free access to this content
    Targeting p53 in melanoma

    Pigment Cell & Melanoma Research

    Volume 27, Issue 1, January 2014, Pages: 8–10, Neil F. Box, Tyler O. Vukmer and Tamara Terzian

    Article first published online : 1 NOV 2013, DOI: 10.1111/pcmr.12180

  13. You have full text access to this OnlineOpen article
    MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL

    International Journal of Cancer

    Volume 130, Issue 9, 1 May 2012, Pages: 2054–2061, Hua-Jie Dong, Cheng Fang, Lei Fan, Dan-Xia Zhu, Dong-Mei Wang, Hua-Yuan Zhu, Yun Zhuang, Kou-Rong Miao, Peng Liu, Wei Xu and Jian-Yong Li

    Article first published online : 9 AUG 2011, DOI: 10.1002/ijc.26222

  14. Podocyte loss involves MDM2-driven mitotic catastrophe

    The Journal of Pathology

    Volume 230, Issue 3, July 2013, Pages: 322–335, Shrikant R Mulay, Dana Thomasova, Mi Ryu, Onkar P Kulkarni, Adriana Migliorini, Hauke Bruns, Regina Gröbmayr, Elena Lazzeri, Laura Lasagni, Helen Liapis, Paola Romagnani and Hans-Joachim Anders

    Article first published online : 7 JUN 2013, DOI: 10.1002/path.4193

  15. You have full text access to this OnlineOpen article
    Differential sensitivity of the inner ear sensory cell populations to forced cell cycle re-entry and p53 induction

    Journal of Neurochemistry

    Volume 112, Issue 6, March 2010, Pages: 1513–1526, Marilin Sulg, Anna Kirjavainen, Katri Pajusola, Hansruedi Bueler, Jukka Ylikoski, Marikki Laiho and Ulla Pirvola

    Article first published online : 26 DEC 2009, DOI: 10.1111/j.1471-4159.2009.06563.x

  16. Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma

    Pediatric Blood & Cancer

    Ali Rihani, Tom Van Maerken, Bram De Wilde, Fjoralba Zeka, Geneviève Laureys, Koen Norga, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes H. Schulte, Angelika Eggert, Raymond L. Stallings, Frank Speleman and Jo Vandesompele

    Article first published online : 4 JAN 2014, DOI: 10.1002/pbc.24927

  17. Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome

    International Journal of Cancer

    Volume 132, Issue 9, 1 May 2013, Pages: 2044–2055, Maral Jamshidi, Marjanka K. Schmidt, Thilo Dörk, Montserrat Garcia-Closas, Tuomas Heikkinen, Sten Cornelissen, Alexandra J. van den Broek, Peter Schürmann, Andreas Meyer, Tjoung-Won Park-Simon, Jonine Figueroa, Mark Sherman, Jolanta Lissowska, Garrett Teoh Hor Keong, Astrid Irwanto, Marko Laakso, Sampsa Hautaniemi, Kristiina Aittomäki, Carl Blomqvist, Jianjun Liu and Heli Nevanlinna

    Article first published online : 25 OCT 2012, DOI: 10.1002/ijc.27884

  18. Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death

    International Journal of Cancer

    Volume 132, Issue 10, 15 May 2013, Pages: 2248–2257, Laura Conradt, Annika Henrich, Matthias Wirth, Maximilian Reichert, Marina Lesina, Hana Algül, Roland M. Schmid, Oliver H. Krämer, Dieter Saur and Günter Schneider

    Article first published online : 26 NOV 2012, DOI: 10.1002/ijc.27916

  19. Common Polymorphisms in the MDM2 and TP53 Genes and the Relationship between TP53 Mutations and Patient Outcomes in Glioblastomas

    Brain Pathology

    Volume 19, Issue 2, April 2009, Pages: 188–194, Izabela Zawlik, Daisuke Kita, Salvatore Vaccarella, Michel Mittelbronn, Silvia Franceschi and Hiroko Ohgaki

    Article first published online : 6 MAY 2008, DOI: 10.1111/j.1750-3639.2008.00170.x

  20. You have free access to this content
    Editorial Comment from Dr Shiina to Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: A meta-analysis

    International Journal of Urology

    Volume 19, Issue 10, October 2012, Pages: 921–922, Hiroaki Shiina

    Article first published online : 17 JUL 2012, DOI: 10.1111/j.1442-2042.2012.03083.x